IFF Maps Consumer 'Moments' to Counter GLP-1 Caloric Drop
AI-generated image · Bay Street Wire
A new report from the flavors and fragrances giant identifies ten specific eating occasions to help manufacturers pivot as weight-loss drugs reshape food demand.
IFF (NYSE: IFF) has released a report titled “GLP-1 Consumer Moments of Opportunity,” which identifies ten emerging consumer behaviors among individuals using GLP-1 medications. According to reporting from the Financial Post, the company is shifting the industry conversation away from a simple reduction in food intake toward a model of smaller, more intentional eating occasions.
Yuvraj Arora, president of IFF Taste, stated that the needs of GLP-1 users fluctuate throughout the day. He noted that successful product innovation will require balancing nutrition, functionality, and enjoyment based on these specific occasions.
The report provides a formulation roadmap for manufacturers, highlighting several key "moments" where consumers seek specific product attributes. These include:
* **Protein-First Wake-Up:** A focus on nutrition goals at the start of the day. * **Midday Bridge:** Nourishment between meals that avoids making the consumer feel overly full. * **Post-Dose Recovery Window:** A preference for easy-to-consume formats and mild flavors due to sensory sensitivity or discomfort. * **Planned Indulgence:** A deliberate choice to consume small treats that prioritize flavor and satisfaction. * **End-of-Day Emotional Reset:** A search for comfort via familiar textures and flavors.
Other identified moments include "Nutritional Insurance Checks" to assess daily intake, "On-the-Go Fuel Stops" for portable portions, and specific needs regarding hydration and social occasions. IFF suggests that understanding these granular moments can open new avenues for innovation in the food and beverage sector.